VEGF-C expression was not detected in the breast cancer tissues of 11/73 patients (15.1%); 17/73 (23.3%) of the patients were ‘+’, 26/73 (35.6%) were ‘++’, 12/73 (16.4%) were ‘+++’ and 7/73 (9.6%) were ‘++++’ for VEGF-C. This evidence concerns the gene VEGFC and breast carcinoma.